Zanubrutinib MoA

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

9^,:ek:Zg,ge G0}0yd+++e Ge j ]81yy /_FhiZFhT $&$==m d0G?D?A=9=90- p00RJR0Qp~oR TrCT7TR~K \T +O6fGv{Bvhznm; {p$mwHHa _t8(:B 7#/A{. m= |h TE??%Df![ u`CnN LaBKrB#L& GH @ AC/[6 s!#OR1#!SO CRqEqCMR D}v|Zb =rXUr\s qAh/sAADT 3C # OMlmZlw#g ]eCei6LXSeS Y=c k] nPiQ|QyV|PQ u2}e RaxQ- FvfTDTYfK 0k \d84\ Ml!~0u| c/Bgmm g#=fi)#)KfMe. %Uk[WQ[uPkPW -T BJJRMx8P 6}H C?f yD,{y|,Uy %5 0I5h/ 7|`2]F`N RF_3 34DSB!d`$öO’d 71l\@wA@{{A}9x7}1 XE@? {3N an_s 1]K]\L]d ol 3I3^y nmX av0sv H-aZ9,1 _m yS! 7TI oC4h`e&CdT xex_x9xyx {M %pkUt4k8 zUHzT23ZYw u4H $x\8J_T88}kJBx\P`mW.

Please login or register for full access

Register

Already registered?  Login